Pitching session: Call 7, topic 3: Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response. Session date: Thursday, 25 January 2024 Session time: 10:00-12:30 (CET/Brussels Time)
Golden Tulip Hotel, Leiden, the Netherlands 12:30 CET | Registration opens 13:00 CET | The Johnson & Johnson Innovation Collaboration Model Tess Korthout | Early Innovation Partner, Johnson & Johnson Innovation 13:15 CET | Preclinical Development Michaël Maes | Non-clinical safety Lead, Johnson & Johnson 14:05 CET | Chemistry, Manufacturing and Controls (CMC) Alessandra Orlandi [...]
March 18–20, 2024 | Barcelona, Spain
The County Hall etc.venues - (3rd floor) Belvedere Road London SE1 7PB
April 22-23, 2024 – Congress Center Basel, Switzerland
Copyright ©2020 Protein Alternatives SL. All rights reserved | Legal Notice & Privacy Policy
